This group observed an increased level of miR-155 and decreased level of CTLA-4 in effector T-cells of patients with atopic dermatitis, suggesting that miR-155 inhibition of CTLA-4 contribute to activation of effector T-cells in the skin (146). The gene discussed is CTLA4; the disease is atopic eczema.